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The deglycase and chaperone protein DJ-1 is pivotal for cellular oxidative stress
responses and mitochondrial quality control. Mutations in PARK7, encoding DJ-1,
are associated with early-onset familial Parkinson’s disease and lead to pathological
oxidative stress and/or disrupted protein degradation by the proteasome. The aim
of this study was to gain insights into the pathogenic mechanisms of selected DJ-1
missense mutations, by characterizing protein–protein interactions, core parameters
of mitochondrial function, quality control regulation via autophagy, and cellular death
following dopamine accumulation. We report that the DJ-1M26I mutant influences DJ-1
interactions with SUMO-1, in turn enhancing removal of mitochondria and conferring
increased cellular susceptibility to dopamine toxicity. By contrast, the DJ-1D149A mutant
does not influence mitophagy, but instead impairs Ca2+ dynamics and free radical
homeostasis by disrupting DJ-1 interactions with a mitochondrial accessory protein
known as DJ-1-binding protein (DJBP/EFCAB6). Thus, individual DJ-1 mutations have
different effects on mitochondrial function and quality control, implying mutation-specific
pathomechanisms converging on impaired mitochondrial homeostasis.
Keywords: mitochondria, mitophagy, DJ-1, DJBP/EFCAB6, PARK7, SUMO-1
INTRODUCTION
Mitochondria are intimately involved in the pathogenic mechanisms underlying
neurodegenerative diseases. Deficits in mitochondrial oxidative phosphorylation activity,
which is the principal source of cellular energy in neurons, lead to reduced cellular viability
(Schon et al., 2012). Mitochondria are one of the main sites of reactive oxygen species (ROS)
production (Muller et al., 2003; Murphy, 2009), which when dysregulated leads to damage of
mitochondrial components (Adam-Vizi and Chinopoulos, 2006) and functions (D’Autréaux
and Toledano, 2007) contributing to the onset of neurodegeneration (Onyango et al., 2010).
Equally, non-physiological changes in the overall mitochondrial mass reflect an altered balance
between mitochondrial biogenesis and degradation, achieved by a specialized form of autophagy,
known as mitophagy (Boland et al., 2013). Defects in any of the above-mentioned mitochondrial
Frontiers in Molecular Neuroscience | www.frontiersin.org 1 March 2018 | Volume 11 | Article 68
fnmol-11-00068 March 13, 2018 Time: 18:22 # 2
Strobbe et al. Mechanisms of Pathogenic DJ-1 Mutations
pathways can lead to the development and/or progression
of neurodegenerative disorders such as Parkinson’s disease
(PD) (Parker et al., 1989; Narendra and Youle, 2012).
PD is a progressive neurodegenerative disorder (Pankratz
et al., 2009) caused by the degeneration of dopaminergic
neurons in the substantia nigra. Histopathologically, PD
is characterized by the formation of fibrillar cytoplasmic
inclusion, known as Lewy bodies, containing ubiquitin and
α-synuclein, that are found in the substantia nigra as well
as cortical and limbic structures (Kim et al., 2014). Even
though the most frequent types of PD are idiopathic in nature
(Cannon and Greenamyre, 2011; Giordano et al., 2012), around
10% of familial cases are caused by mutations in “PARK”
genes: e.g., PARK1/4/SNCA, PARK2/PARKIN, PARK6/PINK1 and
PARK7/DJ-1, and PARK8/LRRK2 (Polymeropoulos et al., 1997;
Lücking et al., 2000; Abou-Sleiman et al., 2003; Paisán-Ruíz et al.,
2004; Valente et al., 2004).
Mutations in PARK7, which encodes the protein deglycase
DJ-1, cause early-onset recessive Parkinsonism (Bonifati et al.,
2003). DJ-1 is a multifunctional, evolutionary-conserved protein
that is ubiquitously expressed in human tissues, with highest
levels in the testis and the brain (Bonifati et al., 2003, 2004).
DJ-1 is involved in oxidative stress responses (Canet-Avilés
et al., 2004; Ariga et al., 2013), anti-apoptotic signaling (Waak
et al., 2009; Giaime et al., 2010), and protein quality control
(Chen et al., 2010). In addition, DJ-1 is required for correct
mitochondrial morphology and function, being involved in
the degradation of dysfunctional mitochondria via autophagy
(Wang et al., 2012). DJ-1 is mainly cytosolic but, after oxidative
stress, associates with mitochondria promoting the removal of
damaged organelles (Kahle et al., 2009; Wang et al., 2012).
Cells with mutated DJ-1 are also unable to eliminate ROS
sources, leading to cell death (Takahashi-Niki et al., 2004). Several
missense mutations have been identified in DJ-1, including
M26I, A104T, D149A, E163K, and L166P (Bonifati et al., 2003;
Görner et al., 2004; Martinat et al., 2004; Olzmann et al.,
2004; Shendelman et al., 2004; Taira et al., 2004; Blackinton
et al., 2005; Hulleman et al., 2007; Lakshminarasimhan et al.,
2008; Ariga et al., 2013; Maita et al., 2013; Ben-Nissan et al.,
2016). The L166P mutation leads to severe destabilization and
unfolding of DJ-1, resulting in a loss of DJ-1 dimerization.
DJ-1L166P is unable to function as a chaperone (Shendelman
et al., 2004) or a protease (Olzmann et al., 2004), and is unable
to protect cells from H2O2-induced cell death (Görner et al.,
2004; Martinat et al., 2004; Taira et al., 2004). Other DJ-1
mutations (e.g., A104T, E163K, and D149A) appear to reduce
the stability of DJ-1 without causing substantial folding defects or
loss of dimerization (Lakshminarasimhan et al., 2008; Ben-Nissan
et al., 2016). The M26I mutation has been reported to affect
steady-state levels of DJ-1 (Blackinton et al., 2005), probably
by increasing turnover rates and/or decreasing dimerization
(Blackinton et al., 2005; Hulleman et al., 2007), thus abrogating
the anti-oxidative stress function of DJ-1 (Ariga et al., 2013; Maita
et al., 2013).
DJ-1 interacts with several proteins linked to oxidative
stress, proteolysis, SUMOlation, and cell death, such as
E3 SUMO-protein ligase PIAS2α (Takahashi et al., 2001),
death-associated protein 6 (Daxx; Junn et al., 2005), Paraoxonase-
2 (Parsanejad et al., 2014), and the 20S proteasome (Moscovitz
et al., 2015). However, little is known about one of the first
DJ-1-binding proteins (DJBP) to be identified, the DJBP
(Niki et al., 2003), also known as EF-hand calcium-binding
domain-containing protein 6 (EFCAB6). DJBP is known
to act as a negative modulator of androgen receptor (AR)
transcriptional activity (Niki et al., 2003). However, the effect
of DJ-1 mutations on the DJ-1/DJBP interaction, or other
binding partners, and the pathophysiological consequences
DJ-1 accessory protein interactions have remained ill defined.
Here, we show that several DJ-1 mutants (including A104T,
D149A, and E163K) impair the DJ-1-DJBP interaction
without affecting other DJ-1-accessory protein interactions or
influencing the efficiency of DJ-1-dependent mitochondrial
quality control. By contrast, the DJ-1 L166P mutation
not only influences DJ-1 dimerization, but also disrupts
interactions with all accessory proteins tested. Lastly, the DJ-1
M26I mutation abrogates the association between DJ-1 and
SUMO-1, affecting mitochondrial quality control and causing
increased susceptibility to dopamine-induced metabolism
impairment.
MATERIALS AND METHODS
Yeast Two-Hybrid Studies
A plasmid encoding full-length human DJ-1 fused to the LexA
DNA-binding domain in the bait vector pGLex was a gift from
Prof. H. Ariga (Hokkaido University, Sapporo, Japan). For
prey constructs, full-length DJ-1, SUMO-1 (NM_003352.4),
UBC9/UBE2I (NM_003345.4), and DJBP/EFCAB6 (AB073862)
were amplified by PCR from human frontal cortex cDNA
using specific oligonucleotide primers (Supplementary
Table S1) and cloned into the pACT2 vector (Clontech)
between the NcoI and XhoI sites, in-frame with the upstream
GAL4 activation domain (AD) sequence. The pGAD-PIAS2α
construct, encoding human full-length E3 SUMO-protein ligase
PIAS2α (NP_775298.1) fused to the GAL4 AD sequence,
was a gift from Prof. H. Ariga, Hokkaido University,
Sapporo, Japan. A human substantia nigra cDNA library
screen using pGLex-DJ-1 as bait resulted in the generation
of a pGADT7Rec-HIPK2 construct; encoding amino acids
818-884 of homeodomain-interacting protein kinase 2
(HIPK2 isoform 2; NP_001106710.1) fused to the GAL4
AD sequence. A human frontal cortex cDNA library screen
using pGLex-DJ-1 as bait resulted in the generation of a
pGADT7Rec-SIMC1 construct, encoding amino acids 1-245
of SIMC1 (SUMO interacting motifs containing 1, also known
as PLEIAD/C5orf25; Ono et al., 2013) fused to the GAL4 AD
sequence. Full-length Daxx (Junn et al., 2005; NM_001350.4)
was amplified using IMAGE clone IMAGp998C115401Q
(Source Bioscience) and specific oligonucleotide primers
(Supplementary Table S1) and cloned into the BamHI and
XhoI sites of pACT2. The two-hybrid assay was performed
with Saccharomyces cerevisiae L40 cells transformed with the
bait plasmid pGLex-DJ-1 [wild-type (wt) or mutant] and a
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prey plasmid expressing GAL4 AD fused to the indicated
protein. All transformants were plated on selective medium
lacking leucine and tryptophan and the resulting colonies
were tested for β-galactosidase activity by performing a LacZ
freeze-fracture assay as previously described (Harvey et al.,
2004).
Mammalian Expression Constructs
A full-length FLAG-tagged DJ-1 sequence was cloned into
the KpnI and XhoI sites of the pcDNA3.1+ vector to generate
pcDNA3-FLAG-DJ-1. The DJBP cDNA encoding the 570
amino acid isoform (AB073862) was amplified from human
whole-brain cDNA (Clontech) using specific oligonucleotide
primers (Supplementary Table S1) and cloned into the
BamHI and XbaI sites of pRK5myc to generate pRK5myc-
DJBP(570). Sequences encoding amino acids 1–31 and
1–48 of full-length DJBP/EFCAB6 (NM_022785.3) were
amplified from a DKFZ clone (DKFZp686C1630Q; RZPD
German Resource Center for Genome Research) using
specific oligonucleotide primers (Supplementary Table S1)
and cloned into the XhoI and BamHI sites of pEGFP-N1
(Clontech) in-frame with EGFP. The mitochondrial targeting
sequence from human cytochrome c oxidase subunit VIII
A (NM_004074.2) was amplified from human frontal cortex
cDNA (Clontech) using specific oligonucleotide primers
(Supplementary Table S1). An EcoRI/BamHI fragment
was cloned into the MCS of pDsRed1-N1 (Clontech) to
generate pDsRed1-MTS. DJ-1 missense mutations were
introduced into plasmid constructs by PCR-mediated site-
directed mutagenesis (QuikChange, Agilent) using pairs of
complementary oligonucleotide primers (Supplementary
Table S2).
DJ-1/DJBP Interactions
HEK293T cells were cultured in Dulbecco’s modified Eagles
medium (Invitrogen) supplemented with 10% (v/v) fetal
bovine serum (FBS), 100 units/ml penicillin, and 100 µg/ml
streptomycin. Cells were transiently transfected using Effectene
(Qiagen) according to the manufacturers’ instructions. All
stages in protein extraction and the subsequent co-purification
procedure were performed at 4◦C; 24 h post-transfection the
cells were washed in phosphate-buffered saline (PBS) and lysed
in 1% (v/v) Nonidet P-40 buffer (150 µM NaCl, 10 µM
Tris–HCl, pH 8, 1× complete protease inhibitor cocktail, in
PBS) for 1 h. Cell extracts were cleared by centrifugation
at 3,000 × g for 20 min. The protein concentration of
the lysate samples was determined using the Quick Start
Bradford Dye Reagent (BioRad). For co-purification of FLAG-
tagged fusion proteins and associated proteins, lysates were
incubated with anti-FLAG agarose (Sigma) for 2 h. The bound
agarose was washed three times with 0.1% (v/v) Nonidet
P-40 wash buffer (150 µM NaCl, 10 µM Tris–HCl; pH
7.8) before eluting the bound FLAG protein complex by the
addition of FLAG peptide (Sigma). Co-purification or total
lysate samples were resolved by 10% sodium dodecyl sulfate
(SDS)–polyacrylamide gel electrophoresis (PAGE) and subjected
to Western blot analysis with mouse monoclonal anti-FLAG
antibody (M2; Sigma), mouse monoclonal anti-c-myc antibody
(9E11; Abcam), mouse monoclonal anti-DJ-1 antibody (3E8;
Stressgen), rabbit polyclonal anti-DJ-1 antibody (No. 2134; New
England Biolabs), or mouse monoclonal anti-α-tubulin (DM 1A;
Sigma). Bands were visualized by enhanced chemiluminescence
(Amersham Biosciences).
DsRed-Mito Localization
HEK293 cells were seeded in 40 mm TC dishes containing a
poly-L-lysine-coated coverslip and co-transfected with 0.25 µg
pDsRed-Mito and 0.75 µg pEGFP-DJBP constructs. Twenty-
four hours post-transfection the cells were fixed with 4%
(w/v) paraformaldehyde and quenched with 50 mM NH4Cl.
The coverslip was mounted and the slides were examined
using the Zeiss LSM 510 Microscope equipped with argon
(excitation 488 nm) and helium-neon (543 nm and 633 nm)
lasers.
SH-SH5Y Cell Culture and Transfection
The human neuroblastoma cell line SH-SY5Y purchased from
American Type Culture Collection (ATCC, Rockville, MD,
United States) was grown in Dulbecco’s modified eagles
medium:Nutrient Mixture F-12 (DMEM-F12) (Sigma-Aldrich),
supplemented with 10% (v/v) FBS (Lonza), 100 U/ml penicillin,
and 100 mg/ml streptomycin (Life Technologies) at 37◦C
and 5% CO2. Cells were transiently transfected using CaCl2.
On the day before transfection, cells were split in order
to have an appropriate confluence (70%). The next day,
medium was replaced on each plate with fresh medium at
least 1 h before transfection. Later 6 µg of vector DNA
(half the quantities of each for co-transfection), 2 M CaCl2,
and H2O2 were mixed in 1× HBS. The solution was
then added directly to the plate and incubated at 37◦C,
5% CO2, for 16–24 h. After incubation, the transfection
medium was replaced with fresh warm DMEM F12 for
24 h. The pcDNA3.1 (+) FLAG vector was used for over-
expressing wt, M26I, and D149A DJ-1 cDNAs. Successful
expression of FLAG-DJ-1 proteins was verified by Western
blotting.
Cellular Survival Assay
Cell survival was measured using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assays to determine
mitochondrial activity. SH-SY5Y cell lines over-expressing
wt and mutant DJ-1 were plated (50,000 cells per well,
in duplicate) in 24-well plates 3 days before treatment. In
particular, 48 h after transfection, cells were treated with
dopamine 300 µM for 24 h. After treatment, cell medium
was removed and cells were incubated in 0.5 mg/ml MTT
solution for 1 h at 37◦C and 5% CO2. To stop incubation,
MTT solution was removed and dimethyl sulfoxide (DMSO)
was added to solubilize the formazan product. The absorbance
was monitored at 595 nm with VarioskanTM LUX Multimode
Microplate Reader (Thermo Fisher Scientific). The data are
expressed as ratio of viable cells normalized to non-treated
controls.
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Cell Death Analysis
To assay cell death in SH-SY5Y over-expressing wt and mutant
DJ-1, the cells were grown on coverslips and treated with
10 µM cycloheximide N-acetyl-D-sphingosine (C2 ceramide) for
14 h or 100 µM H2O2 for 8 h. After incubation, cells were
washed thoroughly to eliminate apoptotic cells. The percentage
of fluorescent cells before and after a challenge with the apoptotic
drugs was determined de visu by counting at the microscope.
Aequorin Measurements
For the mtAEQ and cytAEQ measurements, the cells, over-
expressing wt and mutant DJ-1, in presence or absence of
H2O2 (2 h, 100 µM) were incubated with 5 µM coelenterazine
for 1–2 h in DMEM supplemented with 1% FBS and then
transferred to the perfusion chamber as previously reported
(Campanella et al., 2004). The aequorin luminescence data
were calibrated off-line into [Ca2+] values, using a computer
algorithm based on the Ca2+ response curve of wt and mutant
aequorins.
Western Blotting Analysis
After treatment with different reagents including CCCP (4–8 h,
10 µM), dopamine (24 h, 100–300 µM), and chloroquine
(CLQ) (8 h, 1:1000), SH-SY5Y cells transiently transfected
with wt and mutant DJ-1 constructs were washed in PBS and
collected by gentle scraping and incubated in ice-cold RIPA
buffer [50 mM Tris–HCl, 150 mM NaCl, 1% (v/v) Triton-
X100, pH 8.0] containing protease and the phosphatase inhibitor
for 30 min on ice. Lysates were centrifuged at 13,000 × g
at 4◦C for 20 min. For subcellular fractionation, cells were
collected in fractionation buffer (250 mM sucrose, 20 mM
HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM Na2-EDTA,
1 mM EGTA, pH to 7.4, supplemented with protease inhibitors,
just prior to use). Cell suspensions were passed through a
26G needle 50–80× and then centrifuged at 900 × g for
5 min at 4◦C. The supernatant was collected and centrifuged
again at 10,000 × g for 10 min at 4◦C. The resulting pellet,
containing a fraction enriched in mitochondria, was suspended
in fractionation buffer and after another centrifugation at
10,000 × g for 5 min at 4◦C, suspended in standard lysis
buffer [50 mM Tris, pH 8.0, 150 mM NaCl, 1% (v/v) Triton-
X100] supplemented with protease inhibitors. After 30 min
incubation on ice, samples were centrifuged for 20 min
at 130,000 × g. Protein concentration was estimated using
the Bradford reagent, and 20 µg of total proteins was
mixed with Laemmli sample buffer and boiled at 95◦C for
2 min. Proteins were resolved by SDS–PAGE and transferred
to nitrocellulose (mdi, Membrane Technologies) or PVDF
(Millipore) membranes. Membranes were blocked in 5% non-
fat dry milk (following manufacturer recommendation) in
1× TBST (25 mM Tris, 0.15 M NaCl, 0.05% Tween-20,
pH 7.5) for 1 h, and then probed with appropriate diluted
primary antibodies in 5% non-fat dry milk overnight at 4◦C.
Antibodies used were: mouse monoclonal anti-p62 1 µg/ml
(MBL); rabbit polyclonal anti-VDAC1 1 µg/ml (Abcam); rabbit
polyclonal anti-LC3 0.5 µg/ml (Novus Biologicals); mouse
monoclonal anti-GAPDH 0.2 µg/ml (Abcam); rabbit polyclonal
anti-ubiquitin at 0.5 mg/ml (Abcam), rabbit polyclonal anti-
PINK1 at 2 µg/ml (Novus Biologicals); mouse monoclonal
anti-Parkin at 2 µg/ml (Sigma–Aldrich); rabbit polyclonal
anti-ATPβ at 1 µg/ml (Abcam); goat polyclonal anti-DJBP
at 0.4 µg/ml (Santa Cruz); rabbit polyclonal anti-DJ-1 at
0.265 µg/ml (Abcam); rabbit polyclonal anti-PARP at 0.5 µg/ml
(Abcam); mouse monoclonal anti-MTCO1 at 1 µg/ml (Abcam);
rabbit polyclonal anti-βIII tubulin at 1 µg/ml (Abcam); and
rabbit polyclonal SUMO-1 1 µg/ml (Cell Signaling). Following
incubation, membranes were washed in 1× TBST (3 × 15 min
at RT) and then probed with the corresponding peroxidase-
conjugated secondary antibody in 5% non-fat milk for 1 h at
RT. After further washing in 1× TBST, blots were developed
using an ECL detection kit (Millipore) and a FluorChem imaging
system. Immunoreactive bands were analyzed by performing
densitometry analysis with ImageJ software (NIH, Bethesda, MD,
United States).
Immunofluorescence and Image Analysis
Cells transiently transfected with wt and mutant DJ-1 were
cultured on poly-D-lysine glass coverslips (24Ø) for 24 h.
After administration of CCCP 10 µM for 8 h, cells were
washed twice in cold PBS (pH 7.4) and fixed in 4% (w/v)
paraformaldehyde for 20 min at RT. Following three washes
in PBS, cells were permeabilized with 0.1% Triton-X100
(AppliChem PanReac) for 10 min at RT and blocked with
3% (w/v) bovine serum albumin for 1 h at RT. All coverslips
were then incubated with primary antibodies (goat polyclonal
anti-DJBP at 0.4 µg/ml, Santa Cruz) and rabbit polyclonal
anti-ATPβ at 1 µg/ml (Abcam) at 4◦C overnight. Following
three washes in PBS, coverslips were incubated in the dark
with a mix of the following secondary antibodies AlexaFluor
594-conjugated anti-goat IgG and AlexaFluor 488-conjugated
anti-rabbit IgG (Invitrogen) at 1:100 for 1 h at RT. After
a final wash, coverslips were mounted with ProLong Gold
antifade reagent (Invitrogen) containing DAPI (Applichem),
for nuclei visualization, and imaged by means of an Olympus
Fluoview 1000 Confocal Laser Scanning System. All images
were analyzed by ImageJ software (NIH, Bethesda, MD,
United States).
Flow Cytometric Analyses
SH-SY5Y cell lines transiently transfected with wt and DJ-1
mutants were treated with 100 µM H2O2 for 20 min or 300 µM
dopamine for 24 h, washed with PBS, harvested with trypsin,
and suspended in warm DMEM F12 containing the appropriate
fluorescent dye. The mitochondrial membrane potential was
assessed upon staining with 1 µM JC-1 (Invitrogen) for 10 min
at 37◦C; mitochondria generated ROS by staining with 5 µM
MitoSOX (Invitrogen) for 10 min at 37◦C. Samples were collected
by means of a BD FACSCalibur and data analyzed with FlowJo
(TreeStar).
Statistical Analysis
Statistical analyses were performed by means of two-way
ANOVA, followed by Bonferroni test for multiple comparisons
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with GraphPad Prism 5. For the immunofluorescence data
Pearson’s/Mander’s correlation test was used. Statistical
significance was accepted at the 95% confidence level
(∗∗∗p< 0.001; ∗∗0.001< p< 0.01; ∗0.01< p< 0.05).
RESULTS
Mutated DJ-1 Isoforms and Their
Interaction With Accessory Proteins
The effect of reported DJ-1 missense variants M26I, E64D,
R98Q, A104T, K130R, D149A, E163K, and L166P on the
formation of DJ-1 dimers was assessed using the yeast two-hybrid
(YTH) system (Figure 1a and Supplementary Figure S1a).
Each of the mutant pGLex-DJ-1 bait constructs was tested
for interaction against the corresponding mutant pACT2-DJ-1
prey constructs (Supplementary Figure S1a). All of the DJ-1
mutants could form heterodimers with wt DJ-1, including L166P
(Figure 1a). However, DJ-1L166P was incapable of homodimer
formation (Figure 1a and Supplementary Figure S1a). These
results support the YTH study of Takahashi-Niki et al. (2004)
and suggest that disruption of DJ-1 dimerization is not a
common pathogenic mechanism underlying DJ-1-related PD
(Supplementary Figure S1a). For this reason, DJ-1 mutants
were also assessed for their ability to interact with a range
of published and newly identified DJ-1 accessory proteins,
using the same YTH system (Figure 1b). Each of the mutant
pGLex-DJ-1 bait constructs was tested for interaction against
Daxx, DJBP/EFCAB6, HIPK2, SUMO-1, UBC9, PIAS2α, and
SIMC1/PLEIAD/C5orf25 prey constructs. Interestingly, the
M26I mutation was found to specifically disrupt the interaction
between DJ-1 and SUMO-1 (Figure 1b). This is likely to
be functionally relevant, because incorrectly SUMOylated DJ-1
becomes insoluble, partly localized in the mitochondria, and
degraded by the proteasome system (Shinbo et al., 2006). By
contrast, the A104T, D149A, and E163K mutations specifically
disrupted interactions between DJ-1 and DJBP. It is also notable
that the L166P mutation abolished all DJ-1-accessory protein
interactions, suggesting that DJ-1 dimerization is required
for DJ-1 to interact with these accessory proteins. Since all
other protein–protein interactions (with Daxx, HIPK2, PIAS2α,
SIMC1/PLEIAD/C5orf25, and UBC9) were unaffected, this
means that at least four pathogenic variants in DJ-1 appear to
operate by disrupting DJ-1/DJBP interactions.
To confirm these findings in a non-yeast system, we tested
these protein–protein interactions with an anti-FLAG affinity
purification procedure, in a mammalian cell expression system
(HEK293T cells). Anti-FLAG affinity resin was used to pull down
N-terminal FLAG-tagged wt and mutant DJ-1 (FLAG-DJ-1),
over-expressed in combination with N-terminal myc-tagged
DJBP (myc-DJBP) (Supplementary Figure S1a). As in the
YTH system, the DJ-1 missense mutations A104T, D149A,
E163K, and L166P (but not wt, M26I, or E64D mutants)
clearly disrupted the interaction between exogenously expressed
FLAG-DJ-1 and myc-DJBP (Figures 1c,d) without affecting
DJ-1–DJ-1 interactions. Currently very little is known about
DJBP, with only one study describing the identification of DJBP
as a DJ-1 interacting protein in vitro and in vivo (Niki et al.,
2003). In that study, the DJBP cDNA was reported to consist
of 2119 nucleotides, encoding a 570 amino-acid protein. We
performed a nucleotide database search, with the 2119 bp cDNA
DJBP sequence, which revealed the identification of additional,
longer DJBP variants. The longest cDNA consisted of 4817
nucleotides, encoding a 1501 amino acid protein, and a slightly
shorter 4459 nucleotide cDNA encoding a 1349 amino acid
protein. The use of online tools to identify potentially functional
protein domains revealed the presence of 17 EF-hand motifs
in the longest DJBP isoform. The presence of numerous EF-
hand motifs, which are Ca2+ binding domains, suggests that
DJBP may function as a Ca2+ binding protein. Bioinformatic
analysis of DJBP for subcellular localization targeting sequences
led to the identification of a predicted N-terminal mitochondrial-
targeting sequence in the longest isoform that was examined
in more detail. A potential R-10 motif was found within the
N-terminal 31 amino acids and numerous potential R-2 motifs
were present within the N-terminal 48 amino acids of the longest
DJBP isoform (Supplementary Figure S1b). To examine these
predicted mitochondrial-targeting motifs experimentally, cDNAs
encoding N-terminal DJBP sequence (signal peptide; SP) were
cloned into an EGFP vector to generate pEGFP-DJBP SP1-31
and pEGFP-DJBP SP1-48 constructs. Each construct was used
to transfect HEK293 cells and the subcellular localization of the
expressed EGFP-tagged DJBP SP fusion was analyzed by confocal
microscopy. To facilitate the analysis, cells were co-transfected
with the mitochondrial marker DsRed-Mito. We found that
EGFP-DJBP SP1-31 did not localize to the mitochondria, as
green fluorescence was detected throughout the cell, including
the nucleus (Figure 1e). However, EGFP-DJBP SP 1-48 was not
uniformly distributed throughout the cell but showed a strong
co-localization with DsRed-Mito (Figure 1f), indicating that this
DJBP signal peptide could confer mitochondrial localization on
EGFP. This analysis also suggests that the signal peptide cleavage
site is likely to be an R-2 motif located between amino acids 32
and 48 (three sites were predicted; Supplementary Figure S1b).
Loss of interaction between DJ-1 and DJBP could therefore
underlie mitochondrial dysfunction and we therefore examined
this in regard to mitochondrial Ca2+ signaling, morphology, and
quality control by autophagy, using DJ-1D149A as an example of a
DJ-1 mutant that does not interact with DJBP.
The DJ-1D149A Mutation Impairs Ca2+
Homeostasis by Increasing Cellular
Sensitivity to Oxidative Stress
We investigated mitochondrial network morphology in SH-
SY5Y cells expressing YFP-tagged wt DJ-1 and DJ-1D149A loaded
with MitoTracker red (Supplementary Figures S1c–e). This
analysis revealed tangible alterations in the overall mitochondrial
network in cells expressing DJ-1D149A (Figures 2A,B). We
also assessed mitochondrial Ca2+ handling using the targeted
luminescent probe Aequorin, which revealed differences in
both the mitochondrial and cytosolic environment in DJ-
1D149A expressing cells. The DJ-1D149A mutant dramatically
increased mitochondrial Ca2+ accumulation compared to cells
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FIGURE 1 | Different DJ-1 mutants disrupt interactions with either SUMO-1 or DJBP. (a) YTH β-galactosidase filter assays measuring the effect of the DJ-1L166P
mutation on DJ-1–DJ-1 dimerization. Representative filters for β-galactosidase activity assay are shown. Blue-colored colonies indicate the detection of
protein–protein interactions. (b) The effect of DJ-1 missense mutations on interactions with binding partners. Mutant DJ-1 baits, indicated on the left side of the
figure, were tested against the accessory protein preys indicated at the top of the figure. Note that mutation M26I disrupts interactions with SUMO-1, A104T, D149A,
and E163K specifically disrupt DJ-1/DJBP interactions and L166P disrupts all DJ-1 accessory protein interactions. (c) Affinity purification and immunoblotting
analyses of HEK293 cell lysates demonstrating that the DJ-1D149A mutant does not influence DJ-1/DJ-1 interactions, but disrupt DJ-1/DJBP interactions. (d) Affinity
purification and immunoblotting analyses of HEK293 cell lysates showing that mutations A104T, D149A, E163K, and L166P also disrupt DJ-1/DJBP interactions in
cellular assays, while retaining DJ-1–DJ-1 interactions. (e,f) Confocal imaging of the subcellular localization of DJBP signal peptide–EGFP fusion proteins
EGFP–DJBP SP1-31 (e) and EGFP–DJBP SP1-48 (f), co-transfected with mitochondrial marker (DsRed-Mito). EGFP–DJBP SP1-31 shows cytoplasmic and nuclear
localization, while EGFP–DJBP SP1-48 is targeted to mitochondria, as shown in the merged images. Scale bar = 10 µm.
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FIGURE 2 | Loss of the DJ-1/DJBP interaction leads to aberrant Ca2+ signaling and redox-stress susceptibility. (A) Representative image of mitochondrial
morphology in SH-SY5Y cells transiently co-transfected with FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1D149A (DJ-1D149A) together with YFP and mitoTracker red to
unveil mitochondrial morphology quantified in (B). [mitochondrial circularity, wt DJ-1: 0.46 ± 0.02, DJ-1D149A: 0.55 ± 0.02; results are shown as mean ± standard
error of the mean (SEM) (n = 3; ∗0.01 < p < 0.05)]. Scale bar = 10 µm. (C,D) Peak values of mitochondrial Ca2+ accumulation recorded with targeted Aequorin
before and after H2O2-induced redox stress (2 h, 100 µM) are presented as a histogram in panel (C) while data points in panel (D) refer to the cytoplasmic Ca2+
accumulation in SH-SY5Y transiently transfected with FLAG-DJ-1 (wt DJ-1) or FLAG-DJ-1D149A constructs [mitochondrial Ca2+ accumulation, untreated Mock:
71.3 ± 0.05, wt DJ-1: 60.1 ± 0.11, DJ-1D149A: 82.8 ± 0.05; 2 h H2O2 100 µM Mock: 31.7 ± 0.05, wt DJ-1: 55.1 ± 0.16, DJ-1D149A: 29.4 ± 0.04; cytoplasmic
Ca2+ accumulation, untreated Mock: 2.8 ± 0.03, wt DJ-1: 4.8 ± 0.01, DJ-1D149A: 2.0 ± 0.01; 2 h H2O2 100 µM Mock: 1.6 ± 0.005, wt DJ-1: 4.5 ± 0.011,
DJ-1D149A: 1.2 ± 0.007; data are shown as mean ± SEM (n = 6; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05)]. (E) Histogram bearing the FACS quantification of
mitochondrial O2- production in SH-SY5Y transiently transfected with FLAG-DJ-1 (wt DJ-1) or FLAG-DJ-1D149A constructs after treatment with 100 µM H2O2 for
20 min [ROS production, untreated Mock: 1.62 ± 0.02, wt DJ-1: 1.78 ± 0.36, DJ-1D149A: 3.98 ± 1.04; 5 min H2O2 100 µM Mock: 3.41 ± 0.74, wt DJ-1:
1.54 ± 0.53, DJ-1D149A: 24.47 ± 10.01; 10 min H2O2 100 µM Mock: 14.81 ± 3.41, wt DJ-1: 6.70 ± 1.76, DJ-1D149A: 23.65 ± 9.32; 15 min H2O2 100 µM Mock:
10.14 ± 2.80, wt DJ-1: 2.81 ± 0.77, DJ-1D149A: 9.56 ± 3.86; 20 min H2O2 100 µM Mock: 14.01 ± 4.18, wt DJ-1: 14.98 ± 4.12, DJ-1D149A: 8.90 ± 3.33; data
were shown as mean ± SEM (n = 3; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05)]. (F) Representative images on the degree of mitochondrial fragmentation
(Continued)
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FIGURE 2 | Continued
following H2O2 treatment for 20 min in SH-SY5Y cells expressing FLAG-DJ-1 (wt DJ-1) or FLAG-DJ-1D149A with relative quantification reported in (G). Nuclei were
labeled with DAPI (blue) whereas mitochondrial morphology was detected with VDAC (red) [degree of fragmentation, untreated Mock: 1.00 ± 0.00, wt DJ-1:
1.48 ± 0.04, DJ-1D149A: 1.73 ± 0.05; 20 min H2O2 Mock: 1.5 ± 0.10, wt DJ-1: 1.40 ± 0.04; DJ-1D149A: 1.61 ± 0.04; data are shown as mean ± SEM (n = 3;
∗∗∗p < 0.001; ∗∗0.001 < p < 0.01)]. Scale bar = 10 µm. (H,I) The degree of cell death (the increase of dead cells presented as percentage and normalized to the
total number of living cells) following treatment with 100 µM H2O2 for 8 h and 10 µM ceramide for 14 h in SH-SY5Y cells expressing either YFP-tagged wt DJ-1,
DJ-1D149A, or DJ-1M26I is depicted by the histograms in panels (H) and (I). [cell death (%): 8 h H2O2 100 µM Mock: 10.4 ± 0.05, wt DJ-1: 5.60 ± 0.04, DJ-1D149A:
18.10 ± 0.0015, DJ-1M26I: 4.7 ± 0.006; 14 h ceramide 10 µM Mock: 45.1 ± 0.7, wt DJ-1: 40.7 ± 0.8, DJ-1D149A: 70.60 ± 1.0, DJ-1M26I: 39.3 ± 0.4; data are
shown as mean ± SEM (n = 4; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05)].
over-expressing wt DJ-1 and controls (mock transfected),
while the cytosolic peaks were decreased at resting condition
(Figures 2C,D). This suggests that the interaction of DJ-
1 with DJBP has a key role in Ca2+ buffering. Moreover,
mitochondrial fragmentation and Ca2+ accumulation in cells
expressing DJ-1D149A leads to increased ROS production
(Supplementary Figure S2a). The same analysis, repeated
following cellular treatment with H2O2 (2 h, 100 µM),
normalized the differences and showed retained Ca2+ tonicity in
cells over-expressing wt DJ-1 but not DJ-1D149A (Figures 2C,D).
This suggests that DJ-1, via interactions with DJBP, plays
a homeostatic role under stress (20’ H2O2, 100 µM), as
corroborated by the increase of mitochondrial generated ROS
(Figure 2E) and mitochondrial network fragmentation already at
resting condition in cells expressing DJ-1D149A (Figures 2F,G).
Interestingly, the overexpression of DJ-1D149A leads to increased
cell death under oxidative stress (8 h H2O2, 100 µM)
(Figure 2H), similar to the response seen for the Ca2+ dependent
pro-apoptotic stimulus ceramide (14 h, 10 µM) (Figure 2I).
By contrast, the DJ-1M26I mutant behaved similarly to wt
DJ-1 in cells exposed to Ca2+ mobilizing stimuli and redox
stress, suggesting that this mutant does not act via the same
pathomechanism as DJ-1D149A.
Effect of DJ-1M26I and DJ-1D149A Mutants
on Mitochondrial Quality Control
Since DJ-1 has been previously implicated in inducing autophagy
of damaged organelles (Ariga et al., 2013; Maita et al., 2013),
we also assessed the effect of the DJ-1M26I and DJ-1D149A
mutants on mitochondrial mass, as well as the efficiency of
mitochondrial quality control by targeted autophagy. Image-
based analysis of mitochondrial network integrity in cells
co-expressing DJ-1M26I and mtGFP did not reveal any visible
alterations (Figures 3A,B) differently from Figures 2A,B.
However, quantification of mitochondrially encoded cytochrome
c oxidase I (MTCO1) by Western blotting indicated a reduction
in protein content both in presence/absence of carbonyl cyanide
m-chlorophenyl hydrazone (CCCP) (8 h, 10 µM), in neurons
expressing DJ-1M26I compared to wt DJ-1 and DJ-1D149A
(Figures 3C,D). Even though under resting conditions, mutant
DJ-1D149A decreases mitochondrial length (Figures 2A,B), both
mitochondrial content measured using the MTCO1/β-tubulin
ratio (Figures 3C,D) and mtDNA number appear to be increased
(Supplementary Figure S2b). The induction of mitochondrial
autophagy (mitophagy), by exposing cells expressing DJ-1D149A
and DJ-1M26I to CCCP (Figures 3C–H), resulted in a greater
reduction of mitochondrial content measured by MTCO-1 and
VDAC amount in DJ-1M26I compared to cells expressing wt DJ-1
or DJ-1D149A (Figures 3C–E,G). To confirm that this reduction
was dependent on mitophagy, we repeated the analysis following
inhibition of autophagy flux by CLQ (8 h, 1:1000), which rescued
mitochondrial VDAC levels. This suggests that removal of mito-
content is mediated by the autophagosome–lysosome pathway
(Figures 3E,F,H). The involvement of mitophagy mediators
in organelle homeostasis was also confirmed by profiling
SQSTM1/P62 and LC3 protein expression (Figures 3F–H).
The degree of PINK1 accumulation and LC3 activation in
mitochondria-enriched fractions was then assessed, revealing
an increase upon CCCP treatment in cells expressing DJ-
1M26I (Figures 3I–K). The recruitment of Parkin occurred with
the same efficiency for all DJ-1 mutants (data not shown),
even though in DJ-1M26I expressing cells the ubiquitination of
proteins is far higher under resting conditions (Figures 3L,M).
However, after treatment with CCCP, ubiquitination was lower
than for wt DJ-1 and DJ-1D149A. This implies a rapid swing
in ubiquitination, which could account for a change in quality
control mechanisms in cells expressing DJ-1M26I secondary to
the accumulation of PINK1. We therefore postulate that in
cells expressing DJ-1M26I, an interdependent relationship might
exist between SUMOylation and ubiquitination of proteins that
could translate into dysregulated mitophagy (Supplementary
Figure S2c).
Pattern of DJBP Expression and
Intracellular Accumulation During
Mitophagy
An initial analysis of DJBP localization using immuno-
fluorescence with a polyclonal anti-DJBP antibody demonstrated
that following CCCP treatment, DJBP translocates to
mitochondria irrespective of the DJ-1 mutant co-expressed
(Figures 4A,B). This was further explored through Western
blotting analysis of whole-cell lysates (Figures 4C–E). DJBP
is found in various isoforms (Supplementary Figure S3a)
and we noticed that during mitophagy the levels of the
DJBP long isoform 1 (180 kDa) and isoform 3 (70 kDa)
are reduced in cells overexpressing DJ-1 and DJ-1M26I
(Figures 4C–E). Mitochondrial fractions were also analyzed
in detail (Supplementary Figures S3b,c) demonstrating that:
(i) isoform 3 of DJBP (70 kDa) translocates from the cytosol
to mitochondria during mitophagy although this effect was
decreased in the presence of DJ-1M26I. This could be either
indicative of: (i) a greater translocation to mitochondria or (ii)
a high degree of DJBP degradation on co-expression with DJ-
1M26I. Interestingly, these data suggest that even though isoform
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FIGURE 3 | Loss of the DJ-1/SUMO interaction deregulates cellular mitophagy. (A) Analysis of mitochondrial morphology in SH-SY5Y cells expressing the
FLAG-DJ-1M26I construct with quantification in (B) [mitochondrial circularity, wt DJ-1: 0.46 ± 0.02, DJ-1M26I: 0.40 ± 0.02; results are shown as mean ± SEM (n = 3;
no variance was observed)]. Scale bar = 10 µm. (C) Immunoblotting analysis of mitochondrial DNA (mtDNA) encoded protein MTCO-1 content after CCCP treatment
(8 h, 10 µM) in SH-SY5Y cells co-transfected with wt FLAG-DJ-1, FLAG-DJ-1D149A, or FLAG-DJ-1M26I constructs 24 h after transfection. Data, quantified in (D), are
shown as mean ± SEM (n = 3; ∗∗∗p < 0.001; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05) [MTCO-1 density relative to βIII tubulin, untreated Mock: 1.00 ± 0.00, wt
DJ-1: 2.15 ± 0.33, DJ-1D149A: 2.84 ± 0.19, DJ-1M26I: 0.81 ± 0.06; 8 h CCCP 10 µM Mock: 0.39 ± 0.06, wt DJ-1: 0.98 ± 0.14, DJ-1D149A: 0.74 ± 0.10, DJ-1M26I:
0.18 ± 0.02]. (E–H) Total extracts were then analyzed by Western blotting, testing LC3 degree of activation, p62, and VDAC before and after treatment with
chloroquine (CLQ) (8 h, 1:1000) (E). Data were normalized on the basis of GAPDH levels and quantified in F–H [p62 density, untreated Mock: 1 ± 0.00,
wt DJ-1: 0.99± 0.06, DJ-1D149A: 0.80± 0.09, DJ-1M26I: 0.96± 0.06; 8 h CCCP 10 µM Mock: 1.19± 0.12, wt DJ-1: 1.27± 0.19, DJ-1D149A: 1.49± 0.13, DJ-1M26I:
(Continued)
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FIGURE 3 | Continued
0.65 ± 0.18; 8 h CCCP 10 µM + 8 h CLQ 1:1000 Mock: 0.90 ± 0.07, wt DJ-1: 0.94 ± 0.05, DJ-1D149A: 1.24 ± 0.14, DJ-1M26I: 2.00 ± 0.51; (n = 5;
∗0.01 < p < 0.05); VDAC density, untreated Mock: 1 ± 0.00, wt DJ-1: 1.10 ± 0.12, DJ-1D149A: 0.93 ± 0.07, DJ-1M26I: 1.08 ± 0.09; 8 h CCCP 10 µM Mock:
0.70 ± 0.08, wt DJ-1: 0.80 ± 0.09, DJ-1D149A: 0.87 ± 0.15, DJ-1M26I: 0.46 ± 0.14; 8 h CCCP 10 µM + 8 h CLQ 1:1000 Mock: 0.80 ± 0.13, wt DJ-1: 0.82 ± 0.17,
DJ-1D149A: 1.06 ± 0.20, DJ-1M26I: 0.89 ± 0.13 (5 < n < 8, no variance was observed); LC3II/LC3I density, untreated Mock: 1 ± 0.00, wt DJ-1:1.26 ± 0.29,
DJ-1D149A: 1.23 ± 0.18, DJ-1M26I: 1.43 ± 0.21; 8 h CCCP 10 µM Mock: 3.01 ± 0.87, wt DJ-1: 2.23 ± 0.69, DJ-1D149A: 2.76 ± 0.29, DJ-1M26I: 4.07 ± 0.26; 8 h
CCCP 10 µM + 8 h CLQ 1:1000 Mock: 2.31 ± 1.01, wt DJ-1: 2.57 ± 1.48, DJ-1D149A: 2.49 ± 0.81, DJ-1M26I: 3.31 ± 1.49 (3 < n < 7, no variance was observed)].
Data are shown as mean ± SEM. (I–K) Mitochondrial extracts were analyzed by Western blotting using the following antibodies: anti-PINK1, anti-LC3, and anti-ATPβ
(loading control). The graph represents the quantification of PINK1 (J) [PINK1 density, untreated Mock: 0.04 ± 0.03, wt DJ-1: 0.04 ± 0.03, DJ-1D149A: 0.04 ± 0.04,
DJ-1M26I: 0.04 ± 0.03; 8 h CCCP 10 µM Mock: 0.83 ± 0.01, wt DJ-1: 0.81 ± 0.04, DJ-1D149A: 0.71 ± 0.04, DJ-1M26I: 0.98 ± 0.20 (3 < n < 5; no variance was
observed)], and LC3 (K) expression [LC3II density, 8 h CCCP 10 µM Mock: 0.33 ± 0.02, wt DJ-1: 0.20 ± 0.02, DJ-1D149A: 0.46 ± 0.02, DJ-1M26I: 0.49 ± 0.02
(n = 3; ∗∗∗p < 0.001; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05)]. Data are shown as mean ± SEM. In panel (L) a representative Western blot on protein ubiquitination
is shown and quantified in the corresponding graph (M) normalized to GAPDH levels [ubiquitination density, untreated Mock: 1 ± 0.00, wt DJ-1: 1.14 ± 0.01,
DJ-1D149A: 1.13 ± 0.01, DJ-1M26I: 1.40 ± 0.03; 8 h CCCP 10 µM Mock: 1.53 ± 0.01, wt DJ-1: 1.30 ± 0.05, DJ-1D149A: 1.21 ± 0.05, DJ-1M26I: 0.73 ± 0.05; data
are shown as mean ± SEM (n = 3; ∗∗∗p < 0.001; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05).
3 of DJBP is missing the N-terminal 931 aa, it may contribute
to the mitophagic response or act as a mitophagy substrate,
driving hyper-activation of the process overall. In addition,
the 100 and 63 kDa DJBP isoforms were markedly reduced
in whole-cell lysate of cells expressing DJ-1M26I (Figure 4C)
suggesting that these may also activate mitophagy. By contrast,
expression of the DJ-1D149A mutation – which disrupts the
DJ-1/DJBP interaction – is likely to recruit less DJBP to damaged
mitochondria, thus reducing the availability of this important
interactor.
Dopamine Induces Cell Death by
Mitophagy Dysregulation
Dopamine can inhibit Complex I of the mitochondrial
respiratory system, thus disrupting mitochondrial activity
(Brenner-Lavie et al., 2008). Moreover, it causes extensive loss
of cell viability, increased ROS production, and over-expression
and accumulation of intracellular α-synuclein (Banerjee et al.,
2014). When we analyzed metabolic toxicity associated with
mitochondria in dopamine-treated SH-SY5Y cells, we observed
a significant reduction that was greater in cells expressing
DJ-1M26I (Figure 5A). We also investigated1ψm levels and ROS
accumulation finding that after dopamine administration the
1ψm drops sharply, paralleled by an increase in mitochondrial
ROS levels, regardless of the DJ-1 mutant tested (Figures 5B,C).
Notably, the accumulation of ROS in response to dopamine
leads to PARP activation that did not differ between the DJ-1
mutants tested (Figures 5D,E). Interestingly, the mitochondrial
recruitment of DJBP also takes place during dopamine treatment
(Figures 5F,G). Thus, exploitation of dysregulated mitophagy
appears to be the mechanism by which dopamine exhibits greater
toxicity in the cells expressing DJ-1M26I. Since cells expressing
DJ-1M26I are less sensitive to oxidation-induced cell death
(Figure 2H), individual DJ-1 mutants appear to confer different
cellular weaknesses, which only manifest when different insults
are faced.
DISCUSSION
Mitochondria are hubs for the wellbeing of mammalian cells,
particularly in post-mitotic cells, such as neurons, which heavily
rely on their fitness for energy balance, signaling regulation, and
structural preservation. Neurodegenerative conditions therefore
associate with defective mitochondrial physiology. Impairment in
the mechanisms of organelle quality control such as mitophagy
are possible predictable targets to prevent reverse, or at least
mitigate, the pathomechanism onset of neuronal death (East
and Campanella, 2016; Martinez-Vicente, 2017; Matic et al.,
2017). Defective mitochondria underlies the development of
neuropathology, by increasing the susceptibility of neurons to
auto/paracrine stimulations that will ultimately damage them
irreparably, and lead to irreversible demise (Dias et al., 2013).
Mitochondria are very responsive organelles, highly sensitive to
alterations of the molecular pathways that reduce the efficiency
of mitophagy, as the ones involved in neurological conditions
(e.g., the anti-mitophagy protein TSPO) (Gatliff et al., 2014).
In PD, dopamine-secreting cells undergo cell death (Dauer and
Przedborski, 2003), but there is still substantial speculation on the
actual mechanisms underlying the process of demise, and how
these relate to the small proportion of PD cases with a genetic
origin (Dauer and Przedborski, 2003). In the attempt to enlighten
the genetic contribution to idiopathic PD conditions, we focused
on the effect of specific mutations affecting DJ-1, by measuring
their outcome on: (a) DJ-1-accessory protein interactions, (b)
mitochondrial morphology, (c) Ca2+ signaling, and (d) quality
control via targeted autophagy, in order to reveal mutation-
specific effects as well as susceptibility to damaging factors such
as Ca2+ accumulation or redox events. The DJ-1D149A mutation
(which is one of four DJ-1 mutations that specifically disrupts
the interaction between DJ-1 and DJBP) impairs mitochondrial
Ca2+ dynamics, revealing an essential buffering function of
DJBP (Figures 2C,D). This is likely to be instrumental under
conditions of cellular stress, since cells that have disrupted DJ-
1/DJBP interactions were shown to be susceptible to oxidative
stress as well as Ca2+-dependent mechanisms of cell death
(Figures 2H,I). This finding is in line with previous work
(Duchen, 2012) demonstrating that the cellular capacity for
buffering mitochondrial Ca2+ is essential for evading neuronal
damage. However, our analysis also revealed that the loss of
the DJ-1/DJBP interaction was largely irrelevant to mitophagy
(Figures 3C–M).
By contrast, the mutation DJ-1M26I resulted in an aberrant
mitophagy response (Figures 3C–M). DJBP and DJ-1 are
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FIGURE 4 | During mitophagy DJBP is recruited to mitochondria. (A) Representative immunofluorescence of double staining of DJBP (red) and ATPβ (green)
fluorescence in SH-SY5Y cells transfected with FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1 constructs before and after induction of mitophagy via CCCP (8 h,
10 µM). Scale bar = 10 µm. (B) The bar graph shows the quantitative analysis of co-expression levels by Pearson’s coefficient [untreated Mock: 0.72 ± 0.03, wt
DJ-1: 0.76 ± 0.04, DJ-1D149A: 0.74 ± 0.04, DJ-1M26I: 0.71 ± 0.05; 8 h CCCP 10 µM Mock: 0.80 ± 0.04, wt DJ-1: 0.83 ± 0.02, DJ-1D149A: 0.82 ± 0.04, DJ-1M26I:
0.79 ± 0.02; data are shown as mean ± SEM (n = 3; no variance was observed)]. Panel (C) shows Western blot analysis of DJBP in total extracts during mitophagy,
which reveals protein isoforms, analyzed and quantified in (D,E) using anti-DJBP and anti-βIII tubulin (loading control) antibodies [DJBPisoform1 density, untreated
Mock: 1 ± 0.00, wt DJ-1: 0.82 ± 0.002, DJ-1D149A: 0.78 ± 0.001, DJ-1M26I: 1.21 ± 0.248; 8 h CCCP 10 µM Mock: 1.31 ± 0.16, wt DJ-1: 1.07 ± 0.07,
DJ-1D149A: 0.78 ± 0.03, DJ-1M26I: 0.67 ± 0.06; DJBP isoform 3 density, untreated Mock:1 ± 0.00, wt DJ-1:0.95 ± 0.15, DJ-1D149A: 0.90 ± 0.13, DJ-1M26I:
0.96 ± 0.14; 8 h CCCP 10 µM Mock: 0.79 ± 0.04, wt DJ-1: 0.52 ± 0.04, DJ-1D149A: 0.47 ± 0.02, DJ-1M26I: 0.40 ± 0.05; data are shown as mean ± SEM (n = 3;
∗∗∗p < 0.001; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05)].
both relocalized to the mitochondria during treatment with
CCCP, a widely adopted inducer of mitophagy (Supplementary
Figure S3b; Georgakopoulos et al., 2017), suggesting that
DJBP is also involved in mitophagy. However, the degree of
ubiquitination of mitochondrial proteins was far greater when the
DJ-1 interaction with SUMO-1 was impaired (Figures 3L,M,O).
The ubiquitination of mitochondrial proteins represents an
essential step of commitment to autophagic selection, against
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FIGURE 5 | Dopamine-triggered cell death is mediated by dysregulated mitophagy unveiling a specific pathomechanism for DJ-1M26I. (A) Effect of dopamine on
mitochondrial activity. SH-SY5Y cells were transiently co-transfected with FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1 and YFP constructs. Graph shows
mitochondrial activity in cells incubated with 300 µM dopamine for 24 h [MTT, untreated Mock: 1 ± 0.00, wt DJ-1: 0.93 ± 0.09, DJ-1D149A: 0.74 ± 0.10, DJ-1M26I:
0.68 ± 0.11; 24 h dopamine 300 µM Mock: 0.80 ± 0.03, wt DJ-1: 0.61 ± 0.05, DJ-1D149A: 0.55 ± 0.05, DJ-1M26I: 0.14 ± 0.02; data are shown as mean ± SEM
(n = 4; ∗∗∗p < 0.001; ∗∗0.001 < p < 0.01; ∗0.01 < p < 0.05)]. (B) Effect of dopamine on the loss of mitochondrial membrane potential. SH-SY5Y cells were
transiently transfected with FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1. At 24 h after transfection, cells were treated with 300 µM dopamine for 24 h and stained
with 1 µM JC1. The mean JC1 fluorescence intensity was detected using FACS analysis [JC1 ratio, untreated Mock: 1 ± 0.00, wt DJ-1: 1.15 ± 0.01, DJ-1D149A:
0.99 ± 0.01, DJ-1M26I: 1.13 ± 0.04; 24 h dopamine 300 µM Mock: 0.47 ± 0.10, wt DJ-1: 0.42 ± 0.08, DJ-1D149A: 0.41 ± 0.07, DJ-1M26I: 0.38 ± 0.05; data are
shown as mean ± SEM (n = 3; ∗∗0.001 < p < 0.01)]. (C) Effect of dopamine on mitochondrial O2- production. SH-SY5Y cells, transiently transfected with
FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1, were treated with 300 µM dopamine for 24 h and stained with the fluorescent probe MitoSOX 5 µM. The mean
MitoSOX fluorescence intensity was detected using FACS analysis [ROS production, untreated Mock: 1 ± 0.00, wt DJ-1: 1.20 ± 0.18, DJ-1D149A: 3.05 ± 0.36,
DJ-1M26I: 1.13 ± 0.14; 24 h dopamine 300 µM Mock: 3.38 ± 1.38, wt DJ-1: 5.28 ± 0.25, DJ-1D149A: 4.62 ± 0.62, DJ-1M26I: 4.96 ± 0.38; data are shown as
mean ± SEM (3 < n < 6; ∗∗∗p < 0.001). (D,E) SH-SY5Y cells transiently co-transfected with FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1 and YFP constructs were
treated with 300 µM dopamine for 24 h. Total extracts were then analyzed by Western blotting (D) using anti-PARP and anti-GAPDH (loading control) antibodies. (E)
Graphical quantification of cleaved PARP expression. Data were normalized on the basis of GAPDH levels [PARP cl density, 24 h dopamine 300 µM Mock:
1.44 ± 0.04; wt DJ-1: 1.85 ± 0.05, DJ-1D149A: 0.95 ± 0.06, DJ-1M26I: 1.66 ± 0.05 (n = 3; ∗∗∗p < 0.001; ∗∗0.001 < p < 0.01)]. (F,G) DJBP expression after
dopamine treatment. Representative image for double staining of DJBP (red) and ATPβ (green) immunofluorescence in SH-SY5Y cells transfected with FLAG-DJ-1
(wt DJ-1) or mutant FLAG-DJ-1 constructs. Scale bar = 10 µm. (G) The bar graph shows the quantitative analysis of co-expression levels by Pearson’s coefficient
[untreated wt DJ-1: 0.76 ± 0.04, DJ-1D149A: 0.74 ± 0.04, DJ-1M26I: 0.71 ± 0.05; 24 h dopamine 300 µM wt DJ-1: 0.80 ± 0.03, DJ-1D149A: 0.78 ± 0.05, DJ-1M26I:
0.75 ± 0.02; data are shown as mean ± SEM (n = 3; no variance was observed)].
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which we can score mitochondria undergoing mitophagy and
those that are likely to evade the process (Matic et al., 2017). Upon
mitophagy induction, cells over-expressing DJ-1M26I show an
increased turnover of mitochondrial proteins, as suggested by the
analysis of the mtDNA-encoded protein MTCO1 (Figures 3C,D)
and DNA content (Supplementary Figure S2b) at resting
conditions. Mitochondrial proteins were retained during the
full depolarization of the organelles (Figures 3C–E,G), despite
the observation that mitochondrial accumulation of LC3II and
PINK1 proteins is of equal magnitude (Figures 3I–K). These
results led us to speculate that by impairing the interaction
between DJ-1 and SUMO-1, the DJ-1M26I mutation is likely
to favor ubiquitin-mediated mechanisms of degradation, thus
resulting in over-active mitophagy.
Interestingly, high dopamine doses amplify mitophagy,
causing greater susceptibility to metabolism impairment in the
DJ-1M26I mutant (Figure 5A). Neuronal cells expressing this
mutant were nonetheless protected from oxidative stress-induced
cell death (Figure 2H), which could be a consequence of
the upregulated mitophagy. In fact, removal of mitochondria
would reduce the organelle contribution to stimuli exploiting
the accumulation of free radicals. Cells over-expressing wt DJ-1
are therefore protected from this type of demise, likely via the
core-detoxifying function of the protein itself, as revealed by
the analysis of organelle morphology (Figures 2F,G). Parameters
examined in the presence of excessive doses of dopamine,
such as dissipation of 1ψm, accumulation of mitochondrial
ROS, and PARP cleavage (Abeti et al., 2011), respond similarly
regardless of the DJ-1 mutant tested (Figures 5B–E). These
results are peculiar, given that the DJ-1D149A mutation results
in an underlying increased level of free radicals under stress
(H2O2) (Figure 2E). It could be that the lack of interaction with
DJBP promotes a protective outcome at cytosolic level rather
than in mitochondria, whereas a portion of DJ-1 ameliorates the
function of PARP resulting in a normalization of the response
during dopamine treatment (Figures 5D,E). Other mechanisms
are likely to come into play when the inducer of death is different,
such as during acute exposure to H2O2 (Figure 2H) or ceramide
(Figure 2I). Whether the trafficking of DJ-1 and DJBP represents
a factor in the process of mitochondrial selection as well as
toward dopamine susceptibility remains debatable since both
their degree of recruitment to the organelle (Figures 4A,B) and
their specific degradation are unchanged (Figures 4C–E). It must
be noted that the high degree of mitochondrial turnover as well
as the tools for DJBP detection might represent a bias in the
assessment of both these processes.
Nevertheless, taken together, our findings demonstrate that
loss of interaction between DJ-1 and DJBP is a common
pathomechanism of DJ-1 mutations, and leads to aberrant
Ca2+ signaling that is deleterious in conditions of excessive,
non-physiological, mobilization of Ca2+ as well as during
redox stress (H2O2). The loss of interaction between DJ-1 and
SUMO-1 is a second pathomechanism that does not affect these
processes, but is nonetheless pivotal in increasing susceptibility
to CCCP and dopamine-driven damage, likely by exploiting the
increase in mitophagy. In conclusion, we propose that different
DJ-1 mutations produce selective mitochondrial pathologies,
resulting in susceptibility to different stressors. This would
in turn suggest that cases associated with genetically defined
DJ-1 mutations should be treated in accordance with this
overall pathophysiological context, including the environmental
stressors which could accelerate neuronal death. In our view,
this investigation confirms the existing interdependence between
genetic background and stressors in PD, as well as indicating
how genetic mutations in PARK7 represent an essential, but
not sufficient, prerequisite for the disease to manifest. Taken
together, our results suggest that there is more to be learnt
about specific cellular pathways underlying PD and once
again place mitochondrial dysfunction center stage in disease
pathogenesis.
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FIGURE S1 | Bioinformatic analysis of DJBP mitochondrial targeting sequence
and validation of DJ-1 mutant expression. (a) Results from YTH β-galactosidase
filter assays measuring the effect of DJ-1 mutations on DJ-1 dimerization (see e.g.,
Figure 1a). The intensity of the detected interaction monitored by β-galactosidase
activity in the presence of the colorless compound X-gal, which turns blue in the
presence of this enzyme, is denoted as follows: (—), no interaction; (+++), strong
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interaction. (b) Potential mitochondrial-targeting motifs in DJBP. Top panel: a
potential R-10 motif in the 1501 amino acid isoform of DJBP compared to similar
motifs in human ornithine transcarbamylase (hOTC) and human malate
dehydrogenase (hMDH2). Lower panel: identification of four R-2 motifs within the
N-terminal sequence in the 1501 amino acid isoform of DJBP compared to similar
motifs in aspartate aminotransferase 2 (hAAT2) and succinyl-CoA synthetase
alpha subunit (hSCSA). (c) SH-SY5Y cells were transiently co-transfected with
pcDNA3.1(+)/FLAG and YFP construct using calcium phosphate method. Green
fluorescence is an indicator that the FLAG-DJ-1-containing transcript is being
expressed. Scale bar = 10 µm. (d) Analysis of steady-state levels of DJ-1
mutants. Whole-cell extracts from SH-SY5Y cells co-transfected with
FLAG-wtDJ-1 or mutant FLAG-DJ-1 and YFP construct was analyzed by Western
blot with anti-FLAG and anti-DJ-1 antibody. Upper band: exogenous FLAG tagged
DJ1; Lower band: endogenous DJ-1. (e) The graph represents the quantification
of endogenous and FLAG-DJ-1 normalized on the basis of GAPDH levels (n = 3).
FIGURE S2 | Mitochondrial O2− production, DNA copy number, and proteins
processing. (a) Mitochondrial O2− was evaluated in SH-SY5Y cells transiently
transfected with FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1 using the fluorescent
probe MitoSOX (5 µM). The graph represents the mean of MitoSOX fluorescence
intensity detected by FACS analysis [ROS production, untreated Mock: 1 ± 0.00,
wt DJ-1: 1.20 ± 0.18, DJ-1D149A: 3.05 ± 0.36, DJ-1M26I: 1.13 ± 0.14; data are
shown as mean ± SEM (n = 3; ∗∗∗p < 0.001)]. (b) Quantification of mtDNA. The
mtDNA copy number/cell was evaluated in SH-SY5Y transiently transfected with
FLAG-DJ-1 (wt DJ-1) or mutant FLAG-DJ-1 constructs [untreated 1 ± 0.00, wt
DJ-1: 1.18 ± 0.07, DJ-1D149A: 1.38 ± 0.15, DJ-1M26I: 1.14 ± 0.02; data are
shown as mean ± SEM (n = 4; ∗0.01 < p < 0.05)]. (c) Representative Western
blot showing the balance in protein ubiquitination and sumoylation in SH-SY5Y
cells expressing the anti-mitophagy protein TSPO, which de-ubiquitinates
mitochondria.
FIGURE S3 | DJBP sequences alignment and pattern during mitophagy. (a)
Isoforms of human DJBP. The C-term portion contains the interaction domain with
DJ-1 in position 1303–1501. Isoform 1 is the canonical sequence of DJBP.
Isoform 2 is missing amino acids 1–152. Isoform 3 is missing amino acids 1–931.
Isoform 4 is missing amino acids 1–1139 and has glutamic acid instead of
methionine at position 1140. Isoform 5 is missing amino acids 1250–1501 and
has an alternative sequence at position 1217–1249. Isoform 6 is missing amino
acids 421–1501 and has an alternative amino acid sequence at position 418–420
(KPD > VRF). (b) Pattern of DJBP isoform expression after CCCP treatment (8 h,
10 µM) in mitochondrial fractions of SH-SY5Y cells expressing DJ-1 mutants with
the cytosolic counterpart is reported in (c).
TABLE S1 | Oligonucleotide primers used for cloning. Restriction enzyme
recognition sites within primers are indicated by underlining.
TABLE S2 | Primer sets used for site-directed mutagenesis of DJ-1. The forward
primer is shown above the reverse primer for each mutant. The underlined
sequence indicates the codon containing the nucleotide change.
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